NCT03761225 2023-09-29
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
AB Science
Phase 3 Completed
Clinical Trials
5 trialsNCT01694277 2020-12-08
Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
AB Science
Phase 3 Completed
NCT03766295 2020-12-08
Masitinib Plus Gemcitabine in Pancreatic Cancer
AB Science
Phase 3 Completed
NCT00814073 2019-12-03
AB06006
AB Science
Phase 3 Completed
NCT00789633 2018-12-17
Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer
AB Science
Phase 3 Completed